XML 61 R13.htm IDEA: XBRL DOCUMENT v2.4.0.8
Marketable Securities
9 Months Ended
Sep. 30, 2014
Cash and Cash Equivalents [Abstract]  
Marketable Securities
Marketable Securities
A summary of the Company’s cash, cash equivalents and marketable securities is shown below:
 
Amortized Cost
 
Gross
Unrealized
Gains
 
Gross
Unrealized
Losses
 
Fair Value
 
(in thousands)
As of September 30, 2014
 
 
 
 
 
 
 
Cash and cash equivalents:
 
 
 
 
 
 
 
Cash and money market funds
$
718,562

 
$
1

 
$

 
$
718,563

Total cash and cash equivalents
$
718,562

 
$
1

 
$

 
$
718,563

Marketable securities:
 
 
 
 
 
 
 
Government-sponsored enterprise securities (due within 1 year)
$
467,857

 
$
27

 
$
(16
)
 
$
467,868

Commercial paper (due within 1 year)
46,402

 
94

 

 
46,496

Corporate debt securities (due within 1 year)
213,352

 
2

 

 
213,354

Corporate debt securities (due after 1 year through 5 years)
31,497

 

 
(41
)
 
31,456

Total marketable securities
$
759,108

 
$
123

 
$
(57
)
 
$
759,174

Total cash, cash equivalents and marketable securities
$
1,477,670

 
$
124

 
$
(57
)
 
$
1,477,737

 
 
 
 
 
 
 
 
As of December 31, 2013
 
 
 
 
 
 
 
Cash and cash equivalents:
 
 
 
 
 
 
 
Cash and money market funds
$
569,299

 
$

 
$

 
$
569,299

Total cash and cash equivalents
$
569,299

 
$

 
$

 
$
569,299

Marketable securities:
 
 
 
 
 
 
 
Government-sponsored enterprise securities (due within 1 year)
$
600,496

 
$
7

 
$
(53
)
 
$
600,450

Commercial paper (due within 1 year)
83,384

 
109

 

 
83,493

Corporate debt securities (due within 1 year)
189,674

 
14

 
(34
)
 
189,654

Corporate debt securities (due after 1 year through 5 years)
22,181

 
6

 
(7
)
 
22,180

Total marketable securities
$
895,735

 
$
136

 
$
(94
)
 
$
895,777

Total cash, cash equivalents and marketable securities
$
1,465,034

 
$
136

 
$
(94
)
 
$
1,465,076


The Company has a limited number of marketable securities in insignificant loss positions as of September 30, 2014, which the Company does not intend to sell and has concluded it will not be required to sell before recovery of the amortized costs for the investment at maturity.